Progesterone Capsules

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DLA TROOP SUPPORT

Contract Value

Not provided

Codes & Classification
Solicitation Number

SPE2D2-26-R-0015

NAICS

325412 - Pharmaceutical Preparation Manufacturing

Classification Code

6505

Additional Details
Set Aside

None

Place of Performance

-

SourceSAM
Documents4
The Defense Logistics Agency (DLA) Troop Support, operating under the Department of Defense, has issued a solicitation (SPE2D2-26-R-0015) for the procurement of Progesterone Capsules. This opportunity is classified under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further identified by Product Service Code 6505, indicating a focus on pharmaceuticals and related products. The primary objective of this procurement is to secure a reliable supply of Progesterone Capsules to support the medical and pharmaceutical needs of the Department of Defense. The scope of the solicitation likely encompasses the manufacturing, packaging, and delivery of pharmaceutical-grade progesterone capsules, adhering to stringent quality and regulatory standards required for federal medical supply chains. The intended outcome is to ensure uninterrupted availability of this essential medication for military and associated federal healthcare facilities. Key requirements for this solicitation will include compliance with all applicable federal regulations governing pharmaceutical manufacturing, including but not limited to FDA guidelines and cGMP standards. Offerors should be prepared to demonstrate their capacity for consistent production, quality assurance, and timely delivery of the specified pharmaceutical product. While the specific deliverables and quantities are not detailed in the notice, contractors can expect to provide documentation supporting product quality, traceability, and regulatory compliance as part of their proposal. The contracting activity is managed by DLA Troop Support, a federal office within the Defense Logistics Agency, which is responsible for sourcing and supplying a wide range of medical and pharmaceutical products to the Department of Defense. The primary points of contact for this solicitation are Christopher Newman ([email protected], 445-737-7371) and Jason Wray ([email protected], 445-737-6304), who can provide further information regarding the solicitation process and requirements. This is a formal solicitation, and interested parties should review the associated documents and attachments available on the official SAM.gov opportunity page (https://sam.gov/opp/7bff140d6fca417fafe54d38a7a1f2dd/view) for comprehensive details. The notice is currently active, with a response deadline set for October 2, 2026. Contractors are encouraged to review all solicitation materials thoroughly and ensure their capabilities align with the pharmaceutical manufacturing and supply requirements outlined by DLA Troop Support. No specific set-aside requirements or special considerations are indicated in the provided information. However, as with all federal procurements in the pharmaceutical sector, strict adherence to regulatory, quality, and security standards will be paramount throughout the contract lifecycle. This opportunity is well-suited for established pharmaceutical manufacturers with proven experience in producing and supplying prescription medications to federal agencies. Interested contractors should ensure they meet all regulatory requirements and are prepared to provide comprehensive documentation as part of their proposal submission.